STE — STERIS plc (Ireland) stock price and chart

STE

STERIS plc (Ireland)Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.03% · US Stock Market 0.03% · Russell 3000 0.03%

$205.04-1.44%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

80.0100.0120.0140.0160.0180.0200.0220.0240.0260.0010.0M$205.04

2026-09-18

Price$205.04

MA20$218.70

MA50$234.82

Vol3.7M

What would $1,000 invested in STE be worth today? →

STE returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $205.04
Change YTD: -19.12%
Next earnings: Nov 4, 2026
Market cap: 20B2017-03 6B2026-09 20B+234.3% over the window
Enterprise value: 21.6B
Shares outstanding: 97.5M2017-03 86.1M2026-06 97.5M+13.2% over the window
52W low: $195.14
52W high: $269.44
From 52W high: -23.90%
From 52W low: +5.07%
52W range: 13%
Beta: 0.91

Volume

Rel volume: 2.35×
30D volume: 654.7K
30D $ vol: 147.9M

Fundamentals

Sales (ttm): 6B2017-03 2.6B2026-06 6B+131.1% over the window
Sales/share: $61.922017-03 $30.352026-06 $61.92+104.0% over the window
EPS (ttm): $8.182017-03 $1.282026-06 $8.18+539.0% over the window
FCF (ttm): 925.6M2017-03 251.2M2026-06 925.6M+268.5% over the window
FCF/share: $9.492017-03 $2.922026-06 $9.49+225.4% over the window
Book value/share: $73.912017-03 $32.642026-06 $73.91+126.5% over the window
Net margin: 13.33%2017-03 4.2%2026-06 13.3%+216.8% over the window
ROE: 11.17%2017-03 3.9%2026-06 11.2%+185.5% over the window
ROA: 7.50%2018-03 5.6%2026-06 7.5%+34.1% over the window
Debt / equity: 0.23×2018-03 0.412026-06 0.23-44.2% over the window
Current ratio: 1.912018-03 2.482026-06 1.91-23.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.38%2025-06-30 → 2026-06-305.6B → 6B (+8.4% total)+8.95%2023-06-30 → 2026-06-304.7B → 6B (+29.3% total)+12.13%2021-06-30 → 2026-06-303.4B → 6B (+77.2% total)n/a
Net income: +24.55%2025-06-30 → 2026-06-30646.5M → 805.1M (+24.5% total)+88.94%2023-06-30 → 2026-06-30119.3M → 805.1M (+574.7% total)+23.00%2021-06-30 → 2026-06-30286M → 805.1M (+181.5% total)n/a
FCF: +1.85%2025-06-30 → 2026-06-30908.8M → 925.6M (+1.8% total)+23.30%2023-06-30 → 2026-06-30493.7M → 925.6M (+87.5% total)+16.89%2021-06-30 → 2026-06-30424.1M → 925.6M (+118.2% total)n/a
Shares: -1.01%2025-06-30 → 2026-06-3098.5M → 97.5M (-1.0% total)-0.43%2023-06-30 → 2026-06-3098.8M → 97.5M (-1.3% total)-0.46%2021-06-30 → 2026-06-3099.8M → 97.5M (-2.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +25.18%2025-06-30 → 2026-06-30$6.54 → $8.18 (+25.2% total)+88.54%2023-06-30 → 2026-06-30$1.22 → $8.18 (+570.5% total)+19.62%2021-06-30 → 2026-06-30$3.34 → $8.18 (+144.9% total)n/a
Sales/share: +9.48%2025-06-30 → 2026-06-30$56.56 → $61.92 (+9.5% total)+9.43%2023-06-30 → 2026-06-30$47.26 → $61.92 (+31.0% total)+12.64%2021-06-30 → 2026-06-30$34.15 → $61.92 (+81.3% total)n/a
FCF/share: +2.89%2025-06-30 → 2026-06-30$9.23 → $9.49 (+2.9% total)+23.84%2023-06-30 → 2026-06-30$5.00 → $9.49 (+89.9% total)+17.43%2021-06-30 → 2026-06-30$4.25 → $9.49 (+123.3% total)n/a
Book value/share: +4.64%2025-06-30 → 2026-06-30$70.64 → $73.91 (+4.6% total)+5.78%2023-06-30 → 2026-06-30$62.44 → $73.91 (+18.4% total)+2.32%2021-06-30 → 2026-06-30$65.90 → $73.91 (+12.2% total)n/a
Dividend/share: +10.53%2025-06-30 → 2026-06-30$2.28 → $2.52 (+10.5% total)+10.26%2023-06-30 → 2026-06-30$1.88 → $2.52 (+34.0% total)+9.51%2021-06-30 → 2026-06-30$1.60 → $2.52 (+57.5% total)n/a
Price: -18.16%2025-09-18 → 2026-09-18$250.50 → $205.04 (-18.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-3.49%2023-09-18 → 2026-09-18$228.08 → $205.04 (-10.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.95%2021-09-17 → 2026-09-18$215.09 → $205.04 (-4.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.14%2016-09-16 → 2026-09-18$71.27 → $205.04 (+187.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -17.46%2025-09-18 → 2026-09-18$248.37 → $205.04 (-17.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.57%2023-09-18 → 2026-09-18$221.73 → $205.04 (-7.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.03%2021-09-17 → 2026-09-18$205.38 → $205.04 (-0.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.29%2016-09-16 → 2026-09-18$64.30 → $205.04 (+218.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 25.1×2017-03 54.382026-09 24.83-54.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.5×2017-03 26.442026-09 17.51-33.8% over the window
Fwd P/E: 17.1×
P/S (ttm)Market cap ÷ TTM revenue.: 3.3×2017-03 2.292026-09 3.31+44.7% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.8×2017-03 2.132026-09 2.77+30.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 21.6×2017-03 23.812026-09 21.60-9.3% over the window
EV/EBITDA (fy): 13.2×
EV/Sales (ttm): 3.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.63%2017-03 4.2%2026-06 4.5%+7.7% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 1.23%
Dividend/share (fwd): $2.52
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 97.5M ÷ 98.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.01%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.01%) + dividends paid over that year ($247M) ÷ market_cap_at(2025-06-30) ($23.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($340.4M) ÷ today's market cap ($20B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.70%2017-03 1.6%2026-06 1.7%+2.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $340.4M + TTM dividends $247M) ÷ today's market cap ($20B). Same caveat as the cash buyback yield.: 2.94%2017-03 3.2%2026-06 2.9%-10.0% over the window

Vs own 10Y history

P/E: 0th
P/OI: 6th
P/S: 5th
P/B: 6th
P/FCF: 2nd

Bar = where today’s multiple sits in STE’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-1.44%

-2.71%

-11.77%

+1.20%

YTD

-19.12%

-18.15%

-4.67%

Financial statements

Open full STE financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

STERIS plc (Ireland) (STE) trades at $205.04 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes STE’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full STE financial statements →

STE — STERIS plc (Ireland) price, chart and key statistics